Earl Douglas - SVP, General Counsel at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, General Counsel
Issuer Symbol
ALLO on Nasdaq
All Insider Reports
All Insider Reports

Earl Douglas - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by Earl Douglas for Allogene Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to buy) 512,370 $1,421,624 $9.62 24 Jan 2025 Direct Common Stock
Common Stock 587,848 $1,005,220 $1.71 03 Feb 2025 Direct

Transactions reported by Earl Douglas for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.